Alignment Healthcare (ALHC) CEO trades 298K shares via 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Alignment Healthcare, Inc. CEO and director John E. Kao reported open-market sales of 298,000 shares of common stock on July 10, 2026. The shares were sold in multiple transactions at weighted-average prices of $19.8122 and $20.6471 per share under a Rule 10b5-1 trading plan adopted on November 21, 2025, and include sales from a trust for which Mr. Kao serves as trustee.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary 10b5-1
Net Seller: 298,000 shares ($5,919,361)
Net Sell
3 txns
Insider
KAO JOHN E
Role
Chief Executive Officer
Sold
298,000 shs ($5.92M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 279,644 | $19.8122 | $5.54M |
| Sale | Common Stock | 18,356 | $20.6471 | $379K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 1,107,122 shares (Indirect, See Footnote);
Common Stock — 1,608,743 shares (Direct)
Footnotes (1)
- Date of Rule 10b5-1 plan adoption: 11/21/2025 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.55 to $20.54. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.55 to $20.84. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Key Figures
Shares sold: 298,000 shares
Tranche 1 shares: 18,356 shares
Tranche 2 shares: 279,644 shares
+3 more
6 metrics
Shares sold
298,000 shares
Aggregate common shares sold on July 10, 2026
Tranche 1 shares
18,356 shares
Common stock sold in first reported transaction on July 10, 2026
Tranche 2 shares
279,644 shares
Common stock sold in second reported transaction on July 10, 2026
Weighted-average price tranche 1
$20.6471 per share
Price for the 18,356-share open-market sale
Weighted-average price tranche 2
$19.8122 per share
Price for the 279,644-share open-market sale
Rule 10b5-1 plan adoption date
November 21, 2025
Date the trading plan governing these sales was adopted
Key Terms
Rule 10b5-1 plan, weighted-average price, open-market sale, indirect ownership, +1 more
5 terms
Rule 10b5-1 plan regulatory
"Date of Rule 10b5-1 plan adoption: 11/21/2025"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted-average price financial
"The reported price in column 4 is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
open-market sale market
"Transaction_action is recorded as an open-market sale of common stock."
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
indirect ownership financial
"The "I" code in direct_or_indirect indicates indirect ownership through an entity."
trustee financial
"Represents securities held by JEK Trust, of which Mr. Kao is the trustee."
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.
FAQ
What insider transaction did Alignment Healthcare (ALHC) report for CEO John E. Kao?
Alignment Healthcare (ALHC) reported that CEO John E. Kao sold 298,000 shares of common stock on July 10, 2026. The filing shows two open-market sale transactions executed under a pre-established Rule 10b5-1 trading plan rather than discretionary same-day decisions.
Were John E. Kao’s ALHC stock sales made under a Rule 10b5-1 trading plan?
Yes. A footnote states that the Rule 10b5-1 trading plan governing these sales was adopted on November 21, 2025. Such plans allow pre-scheduled transactions, indicating the timing of these July 10, 2026 sales was set in advance rather than decided opportunistically.